Home Biomedical research Chan Zuckerberg initiative to invest $ 3.4 billion over 10 years in AI, imaging and other technologies to solve biomedical challenges

Chan Zuckerberg initiative to invest $ 3.4 billion over 10 years in AI, imaging and other technologies to solve biomedical challenges


Five years after starting its ambitious goal of funding projects to “cure, prevent or manage all diseases in the lifetimes of our children,” the Chan Zuckerberg Initiative’s Biohub is receiving major momentum.

The philanthropic initiative, led by the husband and wife duo of Facebook founder Mark Zuckerberg and Priscilla Chan, MD, formerly a practicing pediatrician –unveiled this week a 10-year plan to invest $ 3.4 billion in the development of new technologies and tools that help improve our understanding of human health and disease.

Between $ 800 billion and $ 1 billion of the new funds will go to the Biohub, a spokesperson for CZI said. ABC News. The San Francisco-based research center was launched in 2016 with an initial commitment of around $ 600 million. His early projects included building the Cell Atlas, a map of the different cell types that control each major organ, and creating the Infectious Disease Initiative to develop new diagnostic tests and vaccines to treat HIV, Ebola , Zika and others – spread of disease.

The new funding will extend the hub’s operations to at least 2031. Another billion dollars, meanwhile, will help create the CZ Biohub network, which will fund and build new research centers focused on long-term biomedical projects, the first revolutionary being planned for 2023..

Driven in large part by the pandemic, CZ Biohub will redouble its efforts in the areas of infectious diseases and basic sciences by creating new technology platforms, basic data sets and pipelines for large-scale cell biology, all expanding our pathogen detection efforts at home and abroad. “said Joe DeRisi, president of the research center.

RELATED: Zuckerberg & Chan Last Wealthy Philanthropists to Try to ‘Cure All Diseases’

Apart from the Biohub, CZI is spending hundreds of millions more establishing two more R&D facilities.

“In addition to expanding our support for our core science programs in Neurodegeneration, Unicellular Biology, Imaging, Open Science, Rare Disease Research, and Infectious Disease Research, over the next 10 years, CZI Science will focus on creating new tools and technologies to measure human biology in action for the benefit of human health, ”Chan said in a statement.

To this end, the Chan Zuckerberg Institute for Advanced Biomedical Imaging, for its part, will spend the next 15 years bringing together a range of scientists and technologists, with expertise in fields ranging from artificial intelligence to physics in going through biomedical engineering, to develop new imaging systems that give clinicians a clearer view of the inner workings of the human body. It will receive between 600 and 900 million dollars to finance this work.

Finally, CZI will allocate $ 500 million to the Kempner Institute for the Study of Natural and Artificial Intelligence, named after Zuckerberg’s mother and based at Harvard University. There, researchers will study both artificial and human intelligence, using the latter to inform the development of a new, smarter AI that learns, remembers, senses and adapts like the human brain.

RELATED: Chan Zuckerberg Initiative Launches $ 17 Million Digital Imaging Research Program

“To measure the human body in action with spatial precision, biochemical specificity and dynamic precision, we will need new instruments and analytical tools,” Zuckerberg said.

“How can the application of artificial intelligence to biological imaging create new knowledge about the functioning of cells and tissues? How do interactions between cancer cells, surrounding tissues, and the immune system promote or prevent tumor growth? How do the brain and the body communicate to regulate physiological and emotional states? “In collaboration with the scientific community, we will create the teams, build the instruments and validate the uses that make these and other advances possible.”